Patrick Gray
49Patents
18h-index
28Co-inventors
81Inventor score
Filing activity: Feb 27, 1984 → Mar 15, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4727138A | Human immune interferon | Emerging Cross-Sectional Technologies | 95 | Expired |
| US4762791A | Human immune interferon | Emerging Cross-Sectional Technologies | 81 | Expired |
| US4929554A | Human immune interferon | Emerging Cross-Sectional Technologies | 70 | Expired |
| US5574137A | Recombinant gamma interferons having enhanced stability and methods therefor | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5690925A | Recombinant gamma interferons having enhanced stability and methods therefor | Human Necessities | 52 | Expired |
| US5595888A | Recombinant methods of making gamma interferon compositions | Emerging Cross-Sectional Technologies | 51 | Expired |
| US5096705A | Human immune interferon | Human Necessities | 43 | Expired |
| US5932703A | Macrophage derived chemokine and chemokine analogs | Emerging Cross-Sectional Technologies | 41 | Expired |
| US4855238A | Recombinant gamma interferons having enhanced stability and methods therefor | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5582824A | Recombinant DES-CYS-TYR-CYS human immune interferon | Human Necessities | 36 | Expired |
| US6498015B1 | Methods of identifying agents that modulate the binding between MDC and an MDC receptor | Chemistry; Metallurgy | 35 | Expired |
| US4925793A | Human immune interferon | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6268477A | Chemokine receptor 88-C | Chemistry; Metallurgy | 31 | Expired |
| US6265184A | Polynucleotides encoding chemokine receptor 88C | Chemistry; Metallurgy | 31 | Expired |
| US5633145A | TNF.alpha. receptor-derived binding protein | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5532152A | Platelet-activating factor acetylhydrolase | Chemistry; Metallurgy | 23 | Expired |
| US6497871B1 | Recombiniant gamma interferons having enhanced stability and methods therefor | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5863786A | Nucleic acid encoding modified human tnf.alpha. (tumor necrosis factor alpha) receptor | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5759804A | Isolated nucleic acid encoding seven transmembrane receptors | Chemistry; Metallurgy | 17 | Expired |
| US5641669A | Platelet-activating factor acetylhydrolase | Chemistry; Metallurgy | 16 | Expired |
| US6797811B1 | Antibodies to chemokine receptor 88C | Chemistry; Metallurgy | 14 | Expired |
| US5824509A | Recombinant lymphotoxin cDNA and variants | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6203790A | Platelet-activating factor acetylhydrolase | Chemistry; Metallurgy | 12 | Expired |
| US5698403A | Methods of detecting platelet-activating factor acetylhydrolase using antibodies | Chemistry; Metallurgy | 12 | Expired |
| US6399571B1 | Chitinase chitin-binding fragments | Chemistry; Metallurgy | 12 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.